Oded Kraft News Today

US magazine Fast Company, which focuses on technological innovation, has included Israeli high-tech businesses among its prestigious annual list of the world’s most innovative companies.

GrayMatters received US FDA approval for marketing its technology in March and after the start of the Israel-Hamas war received approval in Israel.

With war-related trauma in ample supply, Israel-based GrayMatters Health presses on with the goal of healing PTSD.

As a tech-based solution, neurological biomarkers can be used as a core asset along with the advances in automation and machine learning...

/PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, today announced the expansion of its...

GrayMatters Health, a medtech company based in Israel, has developed Prism for PTSD, a self-neuromodulation therapy. The company has identified what they

The company's product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.

GrayMatters Health recently received 510(k) clearance from the FDA to market its flagship product, which is a self-neuromodulation digital therapy for PTSD. The device uses neurofeedback on specific biomarkers to help patients identify and utilize their own mental strategy for lowering their emotional response.

Also: Diana Health raises $11 million for its maternity care tool.